Amundi Sells 9,062 Shares of Mettler-Toledo International, Inc. $MTD

Amundi decreased its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 7.5% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 111,247 shares of the medical instruments supplier’s stock after selling 9,062 shares during the period. Amundi owned approximately 0.54% of Mettler-Toledo International worth $134,125,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. WPG Advisers LLC bought a new stake in shares of Mettler-Toledo International during the 1st quarter valued at about $41,000. NewSquare Capital LLC increased its holdings in shares of Mettler-Toledo International by 94.4% in the 2nd quarter. NewSquare Capital LLC now owns 35 shares of the medical instruments supplier’s stock worth $41,000 after buying an additional 17 shares during the last quarter. MV Capital Management Inc. increased its holdings in shares of Mettler-Toledo International by 50.0% in the 2nd quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock worth $42,000 after buying an additional 12 shares during the last quarter. Zions Bancorporation National Association UT purchased a new stake in shares of Mettler-Toledo International during the 1st quarter valued at $43,000. Finally, Sound Income Strategies LLC lifted its holdings in shares of Mettler-Toledo International by 477.8% during the 2nd quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock worth $61,000 after acquiring an additional 43 shares during the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Mettler-Toledo International

In related news, insider Gerry Keller sold 236 shares of the firm’s stock in a transaction dated Friday, November 21st. The stock was sold at an average price of $1,418.58, for a total value of $334,784.88. Following the sale, the insider directly owned 159 shares of the company’s stock, valued at $225,554.22. This trade represents a 59.75% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Shawn Vadala sold 1,895 shares of the company’s stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $1,455.52, for a total value of $2,758,210.40. Following the transaction, the chief financial officer directly owned 5,288 shares of the company’s stock, valued at $7,696,789.76. The trade was a 26.38% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 19,565 shares of company stock valued at $28,683,737. Company insiders own 0.77% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on MTD shares. Barclays raised their price target on Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the company an “overweight” rating in a research report on Monday, November 10th. Bank of America raised their price objective on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a report on Monday, September 22nd. Citigroup upped their target price on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a research note on Monday, November 10th. Morgan Stanley initiated coverage on shares of Mettler-Toledo International in a research note on Tuesday, December 2nd. They set an “equal weight” rating and a $1,550.00 price target on the stock. Finally, Evercore ISI upped their price objective on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a research note on Tuesday, October 7th. Five investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $1,419.55.

Mettler-Toledo International Price Performance

Shares of Mettler-Toledo International stock opened at $1,413.49 on Monday. Mettler-Toledo International, Inc. has a one year low of $946.69 and a one year high of $1,525.17. The business’s 50 day simple moving average is $1,389.11 and its two-hundred day simple moving average is $1,284.85. The stock has a market capitalization of $28.88 billion, a P/E ratio of 35.25, a price-to-earnings-growth ratio of 4.57 and a beta of 1.40.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The firm had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $997.36 million. During the same quarter last year, the business earned $10.21 earnings per share. The business’s revenue was up 7.9% on a year-over-year basis. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. Sell-side analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.